@xconomy.com 2 months ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 2 months ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D